96099 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom Five-membered rings
Sub-classes:Tralopyril Derivative and Application Thereof
#2ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#3MODULATORS OF LIVER RECEPTOR HOMOLOGUE 1 (LRH-1) AND USES
#4CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL
#5METHOD FOR PREPARING PHOSPHORUS-CONTAINING LIGAND
#6COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME
#7AMIDE-LINKED CONJUGATE COMPOUNDS AND USES THEREOF
#8PHOSPHORAMIDITE COMPOUNDS AND METHODS FOR PREPARING SYNTHETIC NUCLEIC ACIDS
#9SULFONYLUREA COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#10Synthesis Process of X-IPM, Stable Crystal Form and Application Thereof
#11MODULATORS OF LIVER RECEPTOR HOMOLOGUE 1 (LRH-1) AND USES
#12TRAP1 INHIBITOR AND USE THEREOF
#13ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS
#14ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS
#15SARS-COV-2 MPRO INHIBITOR COMPOUNDS
#16WATER SOLUBLE FLUORSCENT OR COLORED DYES COMPRISING CONJUGATING GROUPS
#17PHOSPHINE REAGENTS FOR AZINE FLUOROALKYLATION
#18Dephosphorylation-controlled extraction of phosphorylatable psychoactive alkaloids
#19OXOPYRROLIDINE FPR2 AGONISTS
#20BUTYL-BRIDGED DIPHOSPHINE LIGANDS FOR ALKOXYCARBONYLATION
#21STAT5 and STAT6 Inhibitors and Uses Thereof
#22Modulators of liver receptor homologue 1 (LRH-1) and uses
#23ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS
#24IONIC LIQUID, ELECTROLYTE FOR SECONDARY BATTERY INCLUDING IONIC LIQUID, AND SECONDARY BATTERY INCLUDING ELECTROLYTE
#25CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL
#26Phosphine reagents for azine fluoroalkylation
#27Methanol-based extraction of psychoactive alkaloids from fungus
#28AMIDE-LINKED CONJUGATE COMPOUNDS AND USES THEREOF
#29A COMPOUND FOR THE DETECTION OF HNO IN BIOLOGICAL SYSTEMS
#30Phenylpyrrolidinone formyl peptide 2 receptor agonists
#31BUTYL-BRIDGED DIPHOSPHINE LIGANDS FOR ALKOXYCARBONYLATION
#32Synthetic Cytotoxic Molecules, Drugs, Methods of Their Synthesis and Methods of Treatment
#33Functionalized polymers
#34Gold(III) complex, a conjugate of the gold(III) complex, a pharmaceutical composition comprising the gold(III) complex and uses and a process for preparing the gold(III) complex
#35OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
#36Ultra bright dimeric or polymeric dyes with spacing linker groups
#37Modulators of liver receptor homologue 1 (LRH-1) and uses
#38Modified ionic liquids containing phosphorus
#39Non-aqueous electrolyte solution for lithium secondary battery and lithium secondary battery including the same
#40Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes
#41Ultra bright dimeric or polymeric dyes with spacing linker groups
#42Phenylpyrrolidinone formyl peptide 2 receptor agonists
#43Phosphonium-ion tethered tetracycline drugs for treatment of cancer
#44Light emitting devices and compouds
#45Modulators of liver receptor homologue 1 (LRH-1) and uses
#46Amide-linked EP4 agonist-bisphosphonate compounds and uses thereof
#47Functionalized polymers
#48Inhibitors of creatine transport and uses thereof
#49Phenylpyrrolidinone formyl peptide 2 receptor agonists
#50Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
#51Organic light-emitting element, and light-emitting material and compound for use therein
#52Sofosbuvir Derivatives for the Treatment of Hepatitis C
#53Manganese (II) complex, preparation method thereof, and use thereof in organic light emitting diodes
#54Charged linkers and their uses for conjugation
#55Charged linkers and their uses for conjugation
#56Charged linkers and their uses for conjugation
#57Hydrophilic linkers and ligand-drug conjugates thereof
#58Method for producing monomer for single-stranded nucleic acid molecule
#59Markovnikov-selective palladium catalyst for carbonylation of alkynes with heteroarenes
#60Method for the synthesis of alpha-aminoalkylenephosphonic acid
#61Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes
#62Phenylethynylnaphthalene dyes and methods for their use
#63STAT6 inhibitors
#64Amide-linked EP4 agonist-bisphosphonate compounds and uses thereof
#65Ultra bright dimeric or polymeric dyes with spacing linker groups
#66Enolase inhibitors and methods of treatment therewith
#67Water soluble fluorescent or colored dyes comprising conjugating groups
#68Ablative, renewable, multi-functional protective coating for dental surfaces
#69Amino phosphazene bases as n-dopants in organic electronics
#70Process for the preparation of acylphosphanes
#71Modified ionic liquids containing phosphorus
#72Pharmaceutical dosage form for immediate release of an indolinone derivative
#73Functional lipid constructs
#74Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
#75Charged linkers and their uses for conjugation
#76Monomers and oligonucleotides comprising cycloaddition adduct(s)
#77Inhibitors of creatine transport and uses thereof
#78Ferrocene-based compounds and palladium catalysts based thereon for the alkoxycarbonylation of ethylenically unsaturated compounds
#79Monophosphine compounds and palladium catalysts based thereon for the alkoxycarbonylation of ethylenically unsaturated compounds
#80Lipid co-factor essential for cell density signaling
#81Azacyclic constrained analogs of FTY720
#82Process for the preparation of acylphosphanes
#83Linkers for conjugation of cell-binding molecules
#84Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
#85Method for the synthesis of aminoalkylenephosphonic acid
#861-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
#87Diphosphine ligand and transition metal complex using the same
#88Phosphoric acid ester derivatives
#89Methods to store transition metal organophosphorous ligand based catalysts
#90Substituted pyrrolidine-2-carboxamides
#91Biocompatible material
#92Monomers and oligonucleotides comprising cycloaddition adduct(s)
#93Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activity
#94NOVEL COMPOUNDS WITH HIGH THERAPEUTIC INDEX
#95Phosphonic acid compounds as inhibitors of serine proteases
#96PROCESS FOR SYNTHESIZING PHOSPHONIC AND PHOSPHINIC ACID COMPOUNDS
#97Endosseous implant
#98Phosphonic acid compounds as inhibitors of serine proteases
#99Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol
#100Substituted propane phosphinic acid derivatives
#101Functionalized polymers
#102Rare-earth complex and uses thereof
#103Swallowtail motifs for imparting water solubility to porphyrinic compounds
#104Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
#105Inhibitors of STAT3 and uses thereof
#106Functional lipid constructs
#107Phosphonic acid compounds as inhibitors of serine proteases
#108PRODRUGS OF ION CHANNEL MODULATING COMPOUNDS AND USES THEREOF
#109AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY
#110NOVEL PYRROLE DERIVATIVES AND THEIR SYNTHESIS
#111Method of ameliorating oxidative stress and supplementing the diet
#112METHOD FOR INTRODUCING FUNCTIONAL GROUP TO SURFACE OF MATERIAL
#113Peptide-lipid constructs and their use in diagnostic and therapeutic applications
#114Phosphonic acid compounds as inhibitors of serine proteases
#115Phosphonic acid compounds as inhibitors of serine proteases
#116Phosphonic acid compounds as inhibitors of serine proteases
#117PURIFICATION OF SYNTHETIC OLIGOMERS
#118Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
#119Organic inorganic composite material and utilization thereof
#120PROCESS FOR THE SYNTHESIS OF FOSINOPRIL AND INTERMEDIATES THEREOF
#121PEGYLATED ION CHANNEL MODULATING COMPOUNDS
#122COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS
#123METHODS FOR GENERATING HIGH TITER HELPER-FREE PREPARATIONS OF RELEASED RECOMBINANT AAV VECTORS
#124N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE
#125Endosseous implant
#126Fluorescent quenching detecting reagents and methods
#127Preparation of diazo and diazonium compounds
#128Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol
#129Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic Bronchitis
#130L-THREONINE DERIVATIVES OF HIGH THERAPEUTIC INDEX
#131L-threonine derivatives of high therapeutic index
#132Method for prophylactic treatment of alzheimer's disease using inhibitors of glutaminyl cyclase and glutamate cyclases
#133Amino alcohol compounds or phosphonic acid derivatives thereof
#134L-Threonine derivatives of high therapeutic index
#135Ligands for transition-metals and methods of use
#136Method for treating a immunology-related disease
#137Swallowtail motifs for imparting water solubility to porphyrinic compounds
#138Nitrons Carrying a Positive Charge and Usable in Trapping Free Radicals, Especially the Superoxide Radical
#139Diphosphine ligand and transition metal complex using the same
#140ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS
#141LIGANDS FOR USE IN ASYMMETRIC HYDROFORMYLATION
#142In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging
#143N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
#144Tetraphosphorus ligands for catalytic hydroformylation and related reactions
#145MANUFACTURE OF PHOSPHORUS-CONTAINING DIAMINES AND THEIR DERIVATIVES
#146Phosphonic acid compounds as inhibitors of serine proteases
#147Novel phosphonic acid compounds as inhibitors of serine proteases
#148Novel phosphonic acid compounds as inhibitors of serine proteases
#149PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
#150Phosphonic acid compounds as inhibitors of serine proteases
#151Process for synthesizing phosphonic and phosphinic acid compounds
#152Novel phosphonic acid compounds as inhibitors of serine proteases
#153Phosphonic acid compounds as inhibitors of serine proteases
#154Novel phosphonic acid compounds as inhibitors of serine proteases
#155Phosphonic acid compounds as inhibitors of serine proteases
#156Novel phosphonic acid compounds as inhibitors of serine proteases
#157Prodrugs of ion channel modulating compounds and uses thereof
#158Novel inhibitors of chymase
#159Antiviral Compounds
#160Cycloolefin phosphine ligands and their use in catalysis
#161N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
#162Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease
#163Inositol-phosphate derivatives and method of detecting inositol-1-phosphate
#164Phosphagen synthesis
#165Methods for generating high titer helper-free preparations of released recombinant AAV vectors
#166Heterobifunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof
#167Protein tyrosine phosphatase inhibitors and methods of use thereof
#168Inhibitors of glutaminyl cyclase
#169Selective inhibitors of neurotensin degrading enzymes
#1702{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidates
#171Method of fabricating organic thin film transistor using self assembled monolayer-forming compound containing dichlorophosphoryl group
#172SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC LIQUIDS
#173Purification of synthetic oligomers
#174Sulfonylethyl phosphorodiamidates
#175Therapeutic compounds
#176Drug conjugates of ion channel modulating compounds
#177Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts
#178Nitrons carrying a positive charge and usable in trapping free radicals, especially the superoxide radical
#179ANDROGEN RECEPTOR MODULATORS AND METHOD OF TREATING DISEASE USING THE SAME
#180Inhibitors of β-lactamase
#181Tetraphosphorus ligands for catalytic hydroformylation and related reactions
#182Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
#183N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
#184Amino alcohol compounds or phosphonic acid derivatives thereof
#185Nitrogen-containing monodentate phosphines and their use in catalysis
#186Amino alcohol compounds
#187Novel chelated bisphosphonates for use as pharmaceutical agents
#188Antiresorptive mutual salt of raloxifene and bisphosphonic acid
#189Antiviral compounds
#190Substituted propane phosphinic acid derivatives
#191Transition-state Inhibitors of Pin1, alpha-Ketoamide-containing peptidomimetics, and synthesis thereof
#192Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for PCR analysis
#193Fluorescent quenching detection reagents and methods
#194L-Threonine derivatives of high therapeutic index
#195Phosphates of secondary alcohols
#196Crystalline form of fosinopril calcium
#197Phosphazenium salt mixtures containing hexakis(amino)diphosphazenium, tetrakis(amino)-phosphonium and polyaminophosphazenium salts
#198Compounds with high therapeutic index
#1991,1-and 1,2-Bisphosphonates as apoliprotein e modulators
#200Anti-inflammatory phosphonate compounds
#201Compositions comprising oxophosphonate-based metalloproteinase inhibitors
#202Catalysts containing N-pyrrolyl substituted nitrogen donors
#203Process for manufacture of fosinopril sodium
#204Protein tyrosine phosphatase inhibitors and methods of use thereof
#205Prodrugs of mitotic kinesin inhibitors
#206Process for manufacture of fosinopril sodium
#207Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
#208Antiviral compounds
#209Novel inhibitors of beta-lactamase
#210Process for manufacture of fosinopril sodium
#211Phosphorus-containing catalyst composition and process for hydroformylation reaction using the same
#212Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
#213Method for producing dialdehydes and or ethylenically unsaturated monoaldehydes by hydroformylating ethylenically unsaturated compounds
#214Androgen receptor modulators and method of treating disease using the same
#215Sulfonylethyl phosphorodiamidates
#216Methods for generating high titer helper-free preparations of released recombinant AAV vectors
#217Mitochondrially targeted antioxidants
#218Inhibitors of chymase
#219Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
#220α-Amino-N-(diaminophosphinyl)lactam derivatives
#221Ligands for use in catalytic processes
#222Phosphinic acids
#223Phosphorous organic compounds and their use
#2241′-benzyl-3-bromo-[1,3′]bipyrrolidinyl-2-one
#225Phosphinic pseudopeptide derivatives for the selective inhibition of the C-terminal active site of angiotensin I converting enzyme (ACE)
#226Use of inhibitors of glutaminyl cyclases for treatment and prevention of disease
#227Catalysts containing N-pyrrolyl substituted nitrogen donors
#228Amino alcohol compounds
#229Inhibitors of β-lactamase
#230Edg receptor agonists
#2318-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
#232Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
#233Method for preparing sulphostin and analogue thereof or preparation intermediate thereof
#234Preparation of crystalline polymorphs of fosinopril sodium